New Chicco Bottles Study
Step-Up
Evaluation of the New Chicco Breast-like and Evolutive Feeding Bottles on Physiological Feeding Parameters and Colic-like Symptoms in Infants
1 other identifier
interventional
61
0 countries
N/A
Brief Summary
Breastfeeding is recommended as the ideal form of nutrition for newborns and infants at least for the first 6 months of life by several Institutions such as the American Academy of Pediatrics (AAP) and the World Health Organization (WHO). When breastfeeding is not possible or not desirable, bottle-feeding, in most cases using a proper infant formula, is the right alternative. Both facial and cranial growth and development rely on genetic and external stimuli; the latter are provided also by activities of sucking, swallowing and chewing. Considering this, it is important to show the differences between the activities of the muscles (masseter, temporalis and buccinator) in charge of sucking during breastfeeding or bottle-feeding. The activities of the muscles were evaluated through SLI, which consists of the assessment of muscle functioning by analyzing the displacement of a defined point on a given muscle. This displacement is tracked over time with respect to a fixed frame of reference, thus providing velocity data (i.e. speed) for a certain point on the muscle during muscle contraction. The use of SLI allowed us to determine the activity of oral muscles on the different types of feeding and to compare their strength and activity. Principal aims of the present study was to assess the activity of the orbicularis oris muscle (OM) and of the masseter, temporalis and buccinator muscles (MM, TM and BM) (i.e. the muscles in charge of sucking during breastfeeding) during breastfeeding and bottle-feeding by means of SLI. The new Chicco feeding bottles Natural Feeling (Natural Fit) 0m+, 4m+ and 6m+ were used according to the age of the infants. Moreover, the following parameters were evaluated comparing breastfeeding and bottle-feeding: feeding efficiency (measured as ml/minute milk intake considering an interval of 15 minutes) and oxygen saturation during feeding (assessed by pulse oximetry). Moreover colic-like symptoms over 9 weeks (0 to 4 weeks infant only) were evaluated through the Infant Colic Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2014
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2015
CompletedFirst Submitted
Initial submission to the registry
October 4, 2017
CompletedFirst Posted
Study publicly available on registry
October 17, 2017
CompletedOctober 18, 2017
October 1, 2017
5 months
October 4, 2017
October 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Mean Velocity orbicularis oris (OM) Muscle by means of SLI
To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups: Treatment groups: bottle-fed infants * Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle * Group 2: age 4 months (+/- 10 days): 4-6 m bottle * Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants * Group 4: age 0-4 weeks (+/- 7 days) * Group 5: age 4 months (+/- 10 days) * Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
Week 2
Mean Velocity masseter MM Muscle by means of SLI
To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups: Treatment groups: bottle-fed infants * Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle * Group 2: age 4 months (+/- 10 days): 4-6 m bottle * Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants * Group 4: age 0-4 weeks (+/- 7 days) * Group 5: age 4 months (+/- 10 days) * Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
week 2
Mean Velocity Temporalis Muscle by means of SLI
To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups: Treatment groups: bottle-fed infants * Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle * Group 2: age 4 months (+/- 10 days): 4-6 m bottle * Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants * Group 4: age 0-4 weeks (+/- 7 days) * Group 5: age 4 months (+/- 10 days) * Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
week 2
Mean Velocity Buccinator Muscle by means of SLI
To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups: Treatment groups: bottle-fed infants * Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle * Group 2: age 4 months (+/- 10 days): 4-6 m bottle * Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants * Group 4: age 0-4 weeks (+/- 7 days) * Group 5: age 4 months (+/- 10 days) * Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
week 2
Secondary Outcomes (15)
ml/minute milk intake during an interval of 15 minutes
week 2
oxygen saturation
week 2
infant colic scale
week 5
infant colic scale
week9
overall product satisfaction (10 points likert scales)
week 2
- +10 more secondary outcomes
Study Arms (6)
Feeding Bottle 0m+
EXPERIMENTAL10 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle. 0-4 months, 250 ml, 2 angled teats: newborn (also referred to as low flow) and infant (also referred to as medium flow), for infants aged 0-4 weeks (+/- 7 days) / over 9 weeks of participation.
Feeding Bottle 4m+
EXPERIMENTAL10 infants aged 4 months (+/- 10 days): 4-6 m bottle. 4-6 months, 250 ml, non-angled teat), for infants aged 4 months (+/- 10 days) / over 9 weeks of participation.
Feeding Bottle 6m+
EXPERIMENTAL10 infants aged 6-10 months (+/- 10 days): 6m+ bottle. 6 months and over, 250 ml, longer teat) for infants aged form 6 to 10 months (+/- 10 days) / over 9 weeks of participation.
exclusively or prevalently breast-fed infants 0m+
NO INTERVENTION10 infants aged 0-4 weeks (+/- 7 days)
exclusively or prevalently breast-fed infants 4m+
NO INTERVENTION10 infants aged 4 months (+/- 10 days)
exclusively or prevalently breast-fed infants 6m+
NO INTERVENTION10 infants aged 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
Interventions
* angled/inclined teat that remains full of milk throughout the feeding to prevent the risk of air ingestion, gassy colic, hiccups and regurgitation and to keep the infant's neck in the right position; * extra-large, soft and rounded base to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion * flexors at the base to enhance elasticity and flexibility of the teat
Eligibility Criteria
You may qualify if:
- Male and female infants aged 0 to 10 months according to the following:
- Group 1: age 0-4 weeks (+/- 7 days) Group 2: age 4 months (+/- 10 days) Group 3: age 6-10 months (+/- 10 days) Group 4: age 0-4 weeks (+/- 7 days) Group 5: age 4 months (+/- 10 days) Group 6: age 6-10 months (+/- 10 days)
- Infants exclusively or prevalently breast- or bottle-fed
- Full-term infants (≥ 37 weeks of gestation) with APGAR at birth (5 min) ≥ 8 by parent report
- Birth weight ≥ 2.5 kg by parent report
- Capability of the parents / legal guardians, according to Investigator's opinion, to fully comprehend the nature of the study
- Parents / legal guardians' written consent to the study and willingness to comply with study procedures
You may not qualify if:
- Birth defect, injury or health condition that interferes with sucking, feeding or breathing
- Any medical condition or disease that may affect subject safety or confound study results, including cardiac or neurological defects
- Infants born from twin or multiple pregnancy
- Any other condition that, in the Investigator's opinion, may preclude the subject's ability to safely complete the trial
- Parents / legal guardians uncooperative and/or non-compliant according to Investigator's opinion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sprim Advanced Life Scienceslead
- Artsana S.p.a.collaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This was a prospective, open-label, monocentric, interventional clinical study.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2017
First Posted
October 17, 2017
Study Start
June 12, 2014
Primary Completion
October 25, 2014
Study Completion
January 5, 2015
Last Updated
October 18, 2017
Record last verified: 2017-10